Nurasykin Yusof, MBChB FRCPA, Consultant Haematologist  Siti Fadilah Abdul Wahid, MD MMed PhD FRCPE
, Senior Consultant Haematologist & Head of Cell Therapy Center  Suria Abdul Aziz, MBBS MPath, Lecturer/ Specialist Haematology 
Hamid Ghodse, CBE, MD, PhD, DSc, DPM, FFPH, FRCP, FRCPE
, FRCPsych, is Professor of Psychiatry and International Drug Policy at the University of London.
An article by Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE
, and Fred Hirsch, MD, PhD, discusses some of the issues and possible solutions that have recently emerged in the complex interface between cancer therapeutics and laboratory biomarker testing.
Kerr, BSc, MB, ChB, FRCPath, FRCPE
, Department of Pathology, Aberdeen Royal Infirmary, Link Building, Foresterhill, Aberdeen, Scotland AB25 2ZD, United Kingdom (email: k.
Further, Aliya Husain, MD, and Edward Garrity, MD, discuss airway changes in patients with lung transplants; Eric Bernicker, MD, describes how a team of clinicians, basic scientists, and pathologists can work together to make true personalized lung cancer therapy a reality; and Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE
, and Marianne Nicolson, MD, FRCP, provide a fascinating examination of PD-L1 as the "third dimension" of lung cancer therapy.